Galya Blachman
General Counsel at 501 ACQU
Network origin in Galya Blachman first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
University of Cambridge
224
| College/University | Other Consumer Services | 224 |
University of Oxford
161
| College/University | Other Consumer Services | 161 |
University of Cape Town
108
| College/University | Other Consumer Services | 108 |
5AM Venture Management LLC
 5AM Venture Management LLC Investment ManagersFinance 5AM Venture Management LLC (5AM Ventures) is an Independent Venture Capital firm founded in 2002 by Andrew J. Schwab, Carin M. Rollins and John D. Diekman. The firm is headquartered in San Francisco, US.
40
| Private Company | Investment Managers | 40 |
| Public Company | Biotechnology | 11 | |
BPP Law School
10
| College/University | Other Consumer Services | 10 |
7
| Private Company | Financial Conglomerates | 7 |
Stemcentrx, Inc.
 Stemcentrx, Inc. BiotechnologyHealth Technology Stemcentrx, Inc. develops life-changing therapies for cancer patients. It develops proprietary discovery platforms that yield unprecedented insight into the biology of tumors and are being exploited to develop potent new cancer drugs. The firm specializes in designing drugs to target cancer stem cells, which are the cells that cause cancer to spread throughout the body. The company was founded by Brian Christopher Slingerland, Daniel T. Reiner and Scott J. Dylla in 2008 and is headquartered in San Francisco, CA.
3
| Extinct | Biotechnology | 3 |
Biotech Connection-Bay Area, Inc.
2
| Private Company | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Galya Blachman via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Enliven Therapeutics, Inc. /US/
 Enliven Therapeutics, Inc. /US/ BiotechnologyHealth Technology EnLiven Therapeutics, Inc. engages in the discovery and development of small molecule treatments for cancer. The company was founded by Samuel S. Kintz and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Founder Founder Founder Director/Board Member | |
| Stanford University | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree Masters Business Admin Doctorate Degree | |
| Massachusetts Institute of Technology | College/University | Corporate Officer/Principal Graduate Degree Doctorate Degree Doctorate Degree | |
Precision NanoSystems, Inc.
 Precision NanoSystems, Inc. Electronic Equipment/InstrumentsElectronic Technology Precision NanoSystems, Inc. manufactures equipment related to testing electricity and electrical Signals. It develops tools and processes for the development and manufacture of nanoparticles for use as medicines and in medical research. The company was founded by Robert James Taylor and Euan Ramsay in 2010 and is headquartered in Vancouver, Canada. | Electronic Equipment/Instruments | Director/Board Member Chairman Director/Board Member Chairman | |
| Harvard Medical School | College/University | Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal | |
| University of Pennsylvania | College/University | Graduate Degree Undergraduate Degree Doctorate Degree Graduate Degree | |
Rallybio LLC
 Rallybio LLC Miscellaneous Commercial ServicesCommercial Services Rallybio LLC operates as a development-stage biotechnology company. The firm develops transformative therapies for patients. It focuses on bringing life-transforming medicines to patients with devastating and rare disorder. The company was founded by Martin Mackay, Stephen Uden and Jeffrey Fryer in 2018 and is headquartered in Farmington, CT. | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member Director/Board Member | |
RareCyte, Inc.
 RareCyte, Inc. Medical SpecialtiesHealth Technology RareCyte Inc. develops life science research and diagnostic that focuses on characterizing and isolating rare cells in the blood. It engages in bringing its technology to the life sciences research, drug development and diagnostic markets providing new tools to answer difficult questions related to cancer and cardiovascular disease. It's ground-breaking sccuCyte system is an open platform for the unbiased discovery and isolation of circulating tumor cells and circulating endothelial cells from whole blood. The company was founded by Ronald Seubert in 2009 and is headquartered in Seattle, WA. | Medical Specialties | Director/Board Member Chief Executive Officer Director/Board Member | |
| IDEAYA BIOSCIENCES, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Director of Finance/CFO | |
| CINCOR PHARMA, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member | |
| VOR BIOPHARMA INC. | Biotechnology | Chairman Chief Executive Officer Director/Board Member | |
Cleave Therapeutics, Inc.
 Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Purigen Biosystems, Inc.
 Purigen Biosystems, Inc. BiotechnologyHealth Technology Purigen Biosystems, Inc. engages in extracting, enriching and quantifying DNA and RNA from biological samples. The company was founded in 2012 by Amy Hiddessen, Klint Rose and Juan Santiago and is headquartered in Pleasanton, CA. | Biotechnology | Director/Board Member Chairman Director/Board Member | |
| EDITAS MEDICINE, INC. | Biotechnology | Corporate Officer/Principal Director/Board Member General Counsel | |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Analyst Private Equity Analyst Private Equity Investor | |
| University of California, Los Angeles | College/University | Masters Business Admin Undergraduate Degree Undergraduate Degree | |
| University of California, Berkeley | College/University | Doctorate Degree Undergraduate Degree Graduate Degree | |
| Boston University | College/University | Undergraduate Degree Undergraduate Degree Director/Board Member | |
| RALLYBIO CORPORATION | Biotechnology | Founder Director/Board Member Director/Board Member | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Consultant / Advisor Corporate Officer/Principal | |
National Venture Capital Association
 National Venture Capital Association Miscellaneous Commercial ServicesCommercial Services National Venture Capital Association provides business association services. It facilitates networking opportunities and provides research data to its members. The company is headquartered in Washington, DC. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Versant Venture Management LLC
 Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver. | Investment Managers | Private Equity Investor Private Equity Investor | |
The Assay Depot, Inc.
 The Assay Depot, Inc. Miscellaneous Commercial ServicesCommercial Services The Assay Depot, Inc. operates as a network of public and private e-commerce marketplaces that connect buyers and sellers of scientific research services. It serves large and small pharmaceutical companies, government institutes, biotechnology companies, academic researchers and citizen scientists. The company was founded by Christopher L. Petersen, Andrew B. Martin, and Kevin D. Lustig in 2007 and is headquartered in Solana Beach, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| The Johns Hopkins University | College/University | Graduate Degree Undergraduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Doctorate Degree | |
| FLEXION THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Ilypsa, Inc.
 Ilypsa, Inc. BiotechnologyHealth Technology Ilypsa, Inc. operates a biopharmaceutical firm. It develops renal care pharmaceutical products. The company was founded on March 6, 2003 and is headquartered in Thousand Oaks, CA. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
Charm Therapeutics Ltd.
 Charm Therapeutics Ltd. BiotechnologyHealth Technology Charm Therapeutics Ltd. is a British London-based company that is discovering and developing small molecule medicines using its proprietary 3D deep learning-enabled platform, Dragonfold. The company aims to create life-changing therapies for difficult-to-drug targets in cancer and other disease areas. Charm Therapeutics has raised $70 million to date and is supported by high-quality international investors, including Orbimed, F-Prime Capital, General Catalyst, Khosla Ventures, Bristol Myers Squibb, NVIDIA, and Grep-VC. The company was founded in 2021 by Laksh Aithani and David Baker, with Laksh Aithani serving as the CEO since then. | Biotechnology | Director/Board Member Director/Board Member | |
| Charm Therapeutics, Inc. | Director/Board Member Director/Board Member | ||
Westlake Biopartners LLC
 Westlake Biopartners LLC Investment ManagersFinance Westlake Biopartners LLC (Westlake Biopartners) is a venture capital firm founded in 2018. The firm is headquartered in Westlake Village, California. | Investment Managers | Private Equity Investor Private Equity Investor | |
| The Rockefeller University | College/University | Graduate Degree Doctorate Degree | |
| 5AM Partners V LLC | Corporate Officer/Principal Corporate Officer/Principal | ||
| The Boston Consulting Group | Consultant / Advisor Consultant / Advisor | ||
| 5AM Opportunities I GP LLC | Corporate Officer/Principal Corporate Officer/Principal | ||
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Amunix Pharmaceuticals, Inc.
 Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | Biotechnology | Chairman Chief Tech/Sci/R&D Officer | |
ARCH Venture Partners LLC
 ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | Investment Managers | Private Equity Analyst Private Equity Investor | |
AviadoBio Ltd.
 AviadoBio Ltd. BiotechnologyHealth Technology AviadoBio Ltd. is a gene therapy company based in London, UK. AviadoBio's technology is based on pioneering research from King's College London and the UK Dementia Research Institute. The British company's mission is to develop and deliver transformative gene therapies for neurodegenerative disorders, including frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). The company is developing AVB-101 for patients with FTD-GRN. AviadoBio's investors include New Enterprise Associates (NEA), Monograph Capital, Advent Life Sciences, EQT Lifesciences, Dementia Discovery Fund (DDF), F-Prime Capital, Johnson & Johnson Innovation – JJDC, Inc. (JJDC), and LifeArc. The company was founded by Youn Bok Lee, Do Young Lee, Chris E. Shaw, and Lisa Deschamps has been the CEO of the company since 2021. | Biotechnology | Director/Board Member Director/Board Member | |
| Imperial College London | College/University | Masters Business Admin Undergraduate Degree | |
Rallybio Holdings LLC
 Rallybio Holdings LLC Medical/Nursing ServicesHealth Services Rallybio Holdings LLC engages in the provision of healthcare services. The company is headquartered in New Haven, CT. | Medical/Nursing Services | Chief Executive Officer Director/Board Member | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree Corporate Officer/Principal | |
| MYOKARDIA, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Operating Officer | |
| AGIOS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
| 5am Partners Vi LLC | Corporate Officer/Principal Corporate Officer/Principal |
Statistics
International
| United States | 43 |
| United Kingdom | 5 |
| Canada | 2 |
| Israel | 2 |
| Mexico | 2 |
Sectoral
| Health Technology | 23 |
| Consumer Services | 13 |
| Finance | 6 |
| Commercial Services | 4 |
| Electronic Technology | 2 |
Operational
| Director/Board Member | 318 |
| Corporate Officer/Principal | 146 |
| Undergraduate Degree | 87 |
| Independent Dir/Board Member | 82 |
| Private Equity Investor | 67 |
Most connected contacts
| Insiders | |
|---|---|
| Andrew Schwab | 45 |
| Richard Heyman | 33 |
| Kush Parmar | 32 |
| John Diekman | 29 |
| Rishi Gupta | 29 |
| Martin MacKay | 28 |
| Jake Bauer | 24 |
| Andrew Phillips | 23 |
| Brian Daniels | 20 |
| Alexander Semenovich Vinokurov | 19 |
| Arthur Tzianabos | 15 |
| David Allison | 15 |
| Elliott Levy | 14 |
| June Lee | 14 |
| Peter Kim | 14 |
- Stock Market
- Insiders
- Galya Blachman
- Company connections
